Format

Send to

Choose Destination
Clin Liver Dis. 2015 May;19(2):223-38. doi: 10.1016/j.cld.2015.01.001. Epub 2015 Feb 26.

Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Author information

1
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: mcglynnk@mail.nih.gov.
2
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892, USA.
3
Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Abstract

Liver cancer is the second leading cause of global cancer mortality. The major risk factors for hepatocellular carcinoma (HCC) are being addressed with success by prevention efforts. Vaccination against hepatitis B virus has reduced incidence of HCC in Taiwan and is partly responsible for lower rates in China. New infections with hepatitis C virus are low in developed countries because of prevention of posttransfusion infections and reduced exposure to HCV by drug users. Aflatoxin exposure has been reduced by better grain storage and dietary changes. Obesity, metabolic syndrome, and diabetes are increasing in developed and developing countries and will lead to more cases of HCC.

KEYWORDS:

Aflatoxin; Alcohol; Chemoprevention; Coffee; Diabetes; Hepatitis B virus; Hepatitis C virus; Incidence

PMID:
25921660
PMCID:
PMC4712629
DOI:
10.1016/j.cld.2015.01.001
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center